Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma

David Baltimore et al. Pigment Cell Melanoma Res. 2010 Apr.

. 2010 Apr;23(2):288-9.

doi: 10.1111/j.1755-148X.2010.00666.x. Epub 2010 Jan 7.

No abstract available

Cited by

Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells.
Smith DJ, Liu S, Ji S, Li B, McLaughlin J, Cheng D, Witte ON, Yang L. Smith DJ, et al. Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1523-8. doi: 10.1073/pnas.1424877112. Epub 2015 Jan 20. Proc Natl Acad Sci U S A. 2015. PMID: 25605948 Free PMC article.
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.
Zhu Y, Smith DJ, Zhou Y, Li YR, Yu J, Lee D, Wang YC, Di Biase S, Wang X, Hardoy C, Ku J, Tsao T, Lin LJ, Pham AT, Moon H, McLaughlin J, Cheng D, Hollis RP, Campo-Fernandez B, Urbinati F, Wei L, Pang L, Rezek V, Berent-Maoz B, Macabali MH, Gjertson D, Wang X, Galic Z, Kitchen SG, An DS, Hu-Lieskovan S, Kaplan-Lefko PJ, De Oliveira SN, Seet CS, Larson SM, Forman SJ, Heath JR, Zack JA, Crooks GM, Radu CG, Ribas A, Kohn DB, Witte ON, Yang L. Zhu Y, et al. Cell Stem Cell. 2019 Oct 3;25(4):542-557.e9. doi: 10.1016/j.stem.2019.08.004. Epub 2019 Sep 5. Cell Stem Cell. 2019. PMID: 31495780 Free PMC article.